We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKS
2401
JinkoSolar
JKS
$891M
$1.78M ﹤0.01%
43,600
-5,800
-12% -$279K
TFSL icon
2402
TFS Financial
TFSL
$4.93B
$1.78M ﹤0.01%
123,574
-59,685
-33% -$816K
USNA icon
2403
Usana Health Sciences
USNA
$286M
$1.78M ﹤0.01%
33,382
-2,999
-8% -$162K
EQRX
2404
DELISTED
EQRx, Inc. Common Stock
EQRX
$1.77M ﹤0.01%
717,920
-265,750
-27% -$1.05M
PLCE icon
2405
Children's Place
PLCE
$59.8M
$1.77M ﹤0.01%
48,473
-523,686
-92% -$19.6M
LGTY
2406
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.76M ﹤0.01%
120,077
-24,578
-17% -$377K
ZGN icon
2407
Zegna
ZGN
$4B
$1.76M ﹤0.01%
160,004
+1,661
+1% +$17.9K
EBS icon
2408
Emergent Biosolutions
EBS
$248M
$1.76M ﹤0.01%
148,701
-22,275
-13% -$345K
DCO icon
2409
Ducommun
DCO
$2.98B
$1.75M ﹤0.01%
35,034
-5,294
-13% -$252K
ITOS
2410
DELISTED
iTeos Therapeutics
ITOS
$1.75M ﹤0.01%
89,428
-10,676
-11% -$209K
TARO
2411
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.75M ﹤0.01%
60,137
+5,292
+10% +$157K
AXGN icon
2412
Axogen
AXGN
$2.5B
$1.74M ﹤0.01%
173,889
+64,963
+60% +$721K
AGX icon
2413
Argan
AGX
$8.37B
$1.73M ﹤0.01%
46,988
-23,185
-33% -$815K
LYEL icon
2414
Lyell Immunopharma
LYEL
$360M
$1.73M ﹤0.01%
24,851
-4,334
-15% -$431K
RAD
2415
DELISTED
Rite Aid Corporation
RAD
$1.72M ﹤0.01%
516,130
-23,573
-4% -$112K
UVE icon
2416
Universal Insurance Holdings
UVE
$1.23B
$1.72M ﹤0.01%
162,668
-93,219
-36% -$948K
SLP icon
2417
Simulations Plus
SLP
$371M
$1.72M ﹤0.01%
47,067
-11,467
-20% -$483K
ARGX icon
2418
argenx
ARGX
$54.1B
$1.72M ﹤0.01%
4,534
-23,216
-84% -$8.68M
FLWS icon
2419
1-800-Flowers.com
FLWS
$258M
$1.72M ﹤0.01%
179,539
-13,004
-7% -$103K
MCW
2420
DELISTED
Mister Car Wash
MCW
$1.71M ﹤0.01%
185,168
-1,152
-0.6% -$10.7K
CEVA icon
2421
CEVA Inc
CEVA
$1.08B
$1.71M ﹤0.01%
66,726
-3,823
-5% -$103K
MCRB icon
2422
Seres Therapeutics
MCRB
$48.4M
$1.71M ﹤0.01%
15,219
-8,017
-35% -$1.07M
SPNT icon
2423
SiriusPoint
SPNT
$2.68B
$1.7M ﹤0.01%
254,583
-42,807
-14% -$252K
FLIC
2424
DELISTED
First of Long Island Corp
FLIC
$1.7M ﹤0.01%
94,202
-9,503
-9% -$172K
TM icon
2425
Toyota
TM
$225B
$1.7M ﹤0.01%
12,418
-504
-4% -$70.3K

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.